Moreover, the activation of FGFR1b signaling pathway promotes the resistance to chemotherapy in AML cells [22], and upregulates the expression of PD-L1 on colorectal cancer via JAK/STAT signaling [23]. This evidence concerns the gene CD274 and acute myeloid leukemia.